RACGAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.722200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.249800E-01
Normal-vs-Stage2
2.402800E-01
Normal-vs-Stage3
9.232200E-01
Normal-vs-Stage4
5.628600E-01
Stage1-vs-Stage2
5.135200E-01
Stage1-vs-Stage3
4.304800E-01
Stage1-vs-Stage4
9.150800E-01
Stage2-vs-Stage3
1.529560E-01
Stage2-vs-Stage4
5.029800E-01
Stage3-vs-Stage4
4.724200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.690400E-01
Normal-vs-AfricanAmerican
4.043200E-01
Normal-vs-Asian
3.228400E-01
Caucasian-vs-AfricanAmerican
4.792600E-01
Caucasian-vs-Asian
7.637700E-02
AfricanAmerican-vs-Asian
9.246200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.368000E-01
Normal-vs-Female
3.327600E-01
Male-vs-Female
2.698000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.378400E-01
Normal-vs-Age(41-60Yrs)
2.140600E-01
Normal-vs-Age(61-80Yrs)
3.090600E-01
Normal-vs-Age(81-100Yrs)
2.556200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.966780E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.784600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.383800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.143500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.913200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.997000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.244600E-01
Normal-vs-Daily Drinker
3.529200E-01
Normal-vs-Weekly Drinker
3.571200E-01
Normal-vs-Occasional Drinker
2.528600E-01
Normal-vs-Social Drinker
1.773240E-01
Non Drinker-vs-Daily Drinker
7.643800E-01
Non Drinker-vs-Weekly Drinker
6.015400E-01
Non Drinker-vs-Occasional Drinker
3.157800E-01
Non Drinker-vs-Social Drinker
6.869800E-01
Daily Drinker-vs-Weekly Drinker
7.954000E-01
Daily Drinker-vs-Occasional Drinker
4.901200E-01
Daily Drinker-vs-Social Drinker
9.148600E-01
Weekly Drinker-vs-Occasional Drinker
7.327400E-01
Weekly Drinker-vs-Social Drinker
8.592200E-01
Occasional Drinker-vs-Social Drinker
5.496400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.974200E-01
Normal-vs-Grade 2
7.969600E-01
Normal-vs-Grade 3
8.567000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.536500E-03
Grade 1-vs-Grade 3
6.370500E-04
Grade 1-vs-Grade 4
6.974200E-01
Grade 2-vs-Grade 3
1.528170E-01
Grade 2-vs-Grade 4
7.969600E-01
Grade 3-vs-Grade 4
8.567000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.669600E-01
Normal-vs-NonDiabetic
2.797200E-01
Diabetic-vs-NonDiabetic
5.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.484400E-02
Normal-vs-NoPancreatitis
3.032200E-01
Pancreatitis-vs-NoPancreatitis
8.405000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.352200E-01
Normal-vs-N1
2.685400E-01
N0-vs-N1
3.932000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.525600E-02
Normal-vs-TP53-NonMutant
2.973800E-01
TP53-Mutant-vs-TP53-NonMutant
6.44709999999549E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
